Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Clover Health Investments Corp shares valued at $999,596 were purchased by Garipalli Vivek on Aug 09 ’24. At $1.88 per share, Garipalli Vivek acquired 531,700 shares. The insider’s holdings grew to 1,409,267 shares worth approximately $5.13 million following the completion of this transaction.
Also, Garipalli Vivek purchased 877,567 shares, netting a total of over 1,000,426 in proceeds. Following the buying of shares at $1.14 each, the insider now holds 877,567 shares.
Before that, Loengard Anna U had added 17,085 shares to its account. In a trade valued at $16,372, the Director bought Clover Health Investments Corp shares for $0.96 each. Upon closing the transaction, the insider’s holdings increased to 17,085 shares, worth approximately $56784.0.
As published in their initiating research note from Craig Hallum on December 17, 2024, Clover Health Investments Corp [CLOV] has been a Buy and the price target has been revised to $6. Analysts at UBS started covering the stock with ‘”a Neutral”‘ outlook in a report released in early October. As of February 02, 2022, Cowen has increased its “an Underperform” rating to a “Market perform” for CLOV. Earlier on February 02, 2022, Canaccord Genuity initiated its rating. Their recommendation was “a Buy” for CLOV stock.
Analyzing CLOV Stock Performance
During the last five days, there has been a surge of approximately 15.56%. Over the course of the year, Clover Health Investments Corp shares have jumped approximately 15.56%. Shares of the company reached a 52-week high of $3.68 on 01/07/25 and a 52-week low of $3.10 on 01/02/25. A 50-day SMA is recorded $3.44, while a 200-day SMA reached $2.26. Nevertheless, trading volume fell to 6.51 million shares from 9.5 million shares the previous day.
Support And Resistance Levels for Clover Health Investments Corp (CLOV)
According to the 24-hour chart, there is a support level at 3.50, which, if violated, would cause prices to drop to 3.35. In the upper region, resistance lies at 3.73. The next price resistance is at 3.82. RSI (Relative Strength Index) is 64.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.26, which suggests the price will decrease in the coming days. Percent R is at 6.35%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
